Biopta is a profitable, award-winning company spin-out from Glasgow
Caledonian University (GCU). Established in 2002, to deliver commercial
products and services developed by university employees, it employs 19
staff across its Glasgow and Beltsville (Maryland USA) offices. It
specialises in the provision of instruments and services monitoring drug
effects in ethically donated, healthy and diseased human tissue, and
counts eight of the top 10 major pharmaceutical companies as clients. To
date, Biopta has provided early stage testing on more than 400 new drugs,
designed to treat conditions such as high blood pressure, asthma and
irritable bowel syndrome, determining their efficacy and potential side
The impact of the research by the Caledonian Environment Centre can be
demonstrated by the shift in Scotland's recycling rates from 4% in 1998
when the Centre was established, to 40% in 2011. The Centre's research
methods were embedded in assessment tools which led to Scottish Councils
being provided with £64m of additional annual funding. The Remade Scotland
programme, hosted and developed by the Centre, between 2000 and 2010,
delivered change as the first recyclate UK market development programme,
and was further developed across the UK: two years later leading to the
establishment of Waste Resources Action Programme (WRAP).
Gender inequality affects workforce effectiveness. Our research has
significantly increased awareness of factors which contribute to the
paucity of female representation in the public sector. Notably it has
shaped the policies and strategies of public sector agencies such the
Scottish Government, Leadership Foundation in Higher Education, NHS and
educational institutions such as universities and further education
colleges. The research provided a platform for implementation of the
Gender Equality Duty for the Scottish public sector.
The primary beneficiaries of Glasgow Caledonian University (GCU)
research into the Gaelic cultural economy are Gaelic-speaking communities
in Scotland. Additional beneficiaries are the Scottish broadcast media and
their Gaelic-speaking viewing public. The research has:
The Unit's research into HIV testing has led to impacts on health policy
(WHO and NICE
guidelines) and services relating to HIV testing amongst vulnerable
populations across Europe,
and particularly, Scotland. The policies related to the frequency of HIV
testing, increases in sites
available for testing, and the scope of interventions to promote testing.
These policies have
contributed to significant increases in HIV testing, and a reduction in
undiagnosed HIV infection,
HIV related ill-health and AIDS deaths. For people living with HIV, this
has enabled improved
quality of life, better health and contributions to society.
Research by Dr S. Karly Kehoe at the Scottish Catholic Archives and the
Highland Archive Centre (HAC) led to the discovery of source materials
relating to connections between Scottish Highlanders and plantation
slavery. Extensive archival work supported an exhibition at the HAC and a
resource pack which currently supports teachers delivering the 'Atlantic
Slave Trade' topic in the National 4/5 Curriculum for Excellence
(History). The pack supports the 'Mandatory Content & Illustrative
Areas' section and covers the 4 core areas for study: the Triangular
Trade; Britain and the Caribbean; the Captive's Experience and Slave
Resistance; the Abolitionist Campaigns.
Glasgow Caledonian University researchers have dramatically changed the
manufacture of custom
ankle-foot and foot orthoses through additive manufacturing (3D printing)
combined with improved
design personalisation. The research has beneficially impacted on health
and well-being as new
3D printed orthoses have been designed and trialled with patients with
positive outcomes reported.
Moreover, European SME companies in the orthotic design and manufacture
benefitted through the commercialisation of new orthotic products and
optimisation software. The research has also led to raised global
awareness of the capabilities of
additive manufacturing for the orthotic sector and beneficially influenced
and development funding at the European policy level.
GCU research into media coverage and public perceptions of poverty, and
measures to tackle poverty has had an impact on policy making, policy
content and the public discourse of poverty. Deprived communities have
been the primary beneficiaries of this impact, e.g. GCU research helped
secure pledges from all the main Scottish political parties to avoid
stigmatising and socially divisive language in discussing poverty.
Secondary beneficiaries have been campaigning organisations whose media
engagement strategies have improved. Finally, GCU poverty research has
informed the Scottish Government's Child Poverty Strategy and the child
poverty measures of Community Planning Partnerships.
The researchers have delivered 10 funded studies (£700,000), 50+ peer-reviewed publications and five knowledge transfer conferences (750+ delegates). The samples presented led to materials being delivered to 100,000+ industry practitioners. Further, the international reach of UK OSH guidance is substantial, influencing Australia, Hong Kong, South Africa, and North America. The research helped improve Occupational Safety & Health (OSH) practices in major construction companies, with global reach, e.g. MACE (3,700 employees, over 69 countries, turnover £1bn), who implemented developed practices, resulting in 30% drop in accident rates. Our 'OSH communication images' are used in CITB training, delivered to over 100,000 workers.
Healthcare Associated Infections (HAI) can be an unintended consequence
of healthcare delivery. They are caused by a range of organisms but are
often preventable. GCU-led research has reduced avoidable infections in
healthcare in the UK and Europe by stimulating policy debate and
investment in new healthcare practice and influencing policy decisions,
evidence guidelines, and educational practices. Important changes have
been made to national and international approaches to meticillin-resistant
Staphylococcus aureus (MRSA) screening with cost savings of £7.5
million to the NHS. 28 European countries now use the HAI point prevalence
survey validation method determined by our research.